Viemed’s Robust Q1 Earnings Signal Growth
Company Announcements

Viemed’s Robust Q1 Earnings Signal Growth

Viemed Healthcare US (VMD) has released an update.

Viemed Healthcare has reported a strong start to 2024 with first-quarter revenues up 28% to $50.6 million and a 21% increase in Adjusted EBITDA, reflecting the company’s successful operational enhancements and strategic growth efforts. With a robust cash balance and no net debt, the company is well-positioned for future expansion, including a new joint venture that underscores its role as a leader in home healthcare innovations. Looking forward, Viemed anticipates continued revenue growth in the second quarter of 2024.

For further insights into VMD stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskViemed Healthcare Reports Strong Q3 2024 Performance
TipRanks Canadian Auto-Generated NewsdeskViemed Healthcare Reports Strong Q3 Financial Results
TipRanks Auto-Generated NewsdeskViemed Healthcare Unveils Investor Deck for Stakeholder Insights
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App